🇺🇸 FDA
Pipeline program

A research study looking at how NNC0487-0111 affects food intake, appetite and metabolism after meals in people with obesity

NN9490-8151

Phase 1 other active

Quick answer

A research study looking at how NNC0487-0111 affects food intake, appetite and metabolism after meals in people with obesity for Participants with obesity, but otherwise healthy is a Phase 1 program (other) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Novo Nordisk A/S
Indication
Participants with obesity, but otherwise healthy
Phase
Phase 1
Modality
other
Status
active

Clinical trials